Health
What’s the Valneva COVID-19 vaccine, the French shot that’s supposed to be ‘variant-proof’? – ABC News
It sounds too good to be true: a vaccine that can protect against future virus variants. But governments around the world are keen to learn more about the Valneva…
A COVID-19 vaccine from French company Valneva has yet to complete clinical trials. But it has caught the eye of governments in the UK, Europe and Australia.
One of the vaccine’s main selling points is its apparent ability to mount a more general immune response against SARS-CoV-2, the virus that causes COVID-19, rather than rely on the spike protein to do this.
This means the vaccine is more likely to be effective against the type of virus variants we’ve already seen emerging, and may emerge in…
Continue Reading
